Sarepta Climbs as Gene Therapy Shows Promise in Early Study

(Bloomberg) -- Sarepta Therapeutics Inc.’s bulls may get some validation after the company’s experimental gene therapy for a rare type of muscular dystrophy improved physical fitness in a trio of p...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.